Rituximab as Initial Therapy in Adult Patients With Minimal Change Disease.
作者信息
Guan Nan, Zhang Min, Zhang Min, Chen Ruiying, Xie Qionghong, Hao Chuan-Ming
机构信息
Division of Nephrology, Huashan Hospital, Fudan University, Shanghai, China.
出版信息
Kidney Int Rep. 2023 Feb 17;8(5):1102-1104. doi: 10.1016/j.ekir.2023.02.1070. eCollection 2023 May.
Abstract
摘要
相似文献
1
Rituximab as Initial Therapy in Adult Patients With Minimal Change Disease.
Kidney Int Rep. 2023 Feb 17;8(5):1102-1104. doi: 10.1016/j.ekir.2023.02.1070. eCollection 2023 May.
2
Efficacy of Semiannual Single Fixed Low-Dose Rituximab Therapy in Steroid-Dependent Minimal Change Nephrotic Syndrome: A Case Series.
Case Rep Nephrol Dial. 2018 Oct 22;8(3):230-237. doi: 10.1159/000493189. eCollection 2018 Sep-Dec.
3
Rituximab in The Management of Pediatric Steroid-Resistant Nephrotic Syndrome: A Systematic Review.
J Pediatr. 2018 Jun;197:191-197.e1. doi: 10.1016/j.jpeds.2018.01.008. Epub 2018 Apr 18.
4
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?
Autoimmun Rev. 2020 Nov;19(11):102671. doi: 10.1016/j.autrev.2020.102671. Epub 2020 Sep 15.
5
Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease.
Kidney Int. 2013 Mar;83(3):511-6. doi: 10.1038/ki.2012.444. Epub 2013 Jan 16.
6
Nephrotic syndrome; is rituximab the light at the end of the tunnel in the treatment of adult steroid-dependent minimal change disease and focal segmental glomerulosclerosis?
J Nephropathol. 2014 Jan;3(1):1-3. doi: 10.12860/jnp.2014.01. Epub 2014 Jan 1.
7
Therapeutic efficacy of rituximab for the management of adult-onset steroid-dependent nephrotic syndrome: a retrospective study.
Clin Exp Nephrol. 2019 Feb;23(2):207-214. doi: 10.1007/s10157-018-1630-y. Epub 2018 Aug 18.
8
Rituximab in Minimal Change Disease: Mechanisms of Action and Hypotheses for Future Studies.
Can J Kidney Health Dis. 2017 Mar 13;4:2054358117698667. doi: 10.1177/2054358117698667. eCollection 2017.
9
Amelioration of the adverse effects of prednisolone by rituximab treatment in adults with steroid-dependent minimal-change nephrotic syndrome.
Clin Exp Nephrol. 2016 Feb;20(1):103-10. doi: 10.1007/s10157-015-1139-6. Epub 2015 Jul 3.
10
Rituximab for Steroid-Dependent Minimal Change Disease in Adults: Is It Time for a Change?
Cureus. 2022 Feb 17;14(2):e22313. doi: 10.7759/cureus.22313. eCollection 2022 Feb.
引用本文的文献
1
Observation of rituximab as initial treatment in patients with minimal change disease- a retrospective study.
Front Immunol. 2025 Apr 24;16:1528996. doi: 10.3389/fimmu.2025.1528996. eCollection 2025.
2
Emerging role of Rituximab in adult minimal change disease: a narrative review of clinical evidence, biomarkers and future perspectives.
BMC Nephrol. 2025 Mar 26;26(1):152. doi: 10.1186/s12882-025-04086-3.
3
The efficacy and safety of half-dose glucocorticoids combined with rituximab versus high-dose glucocorticoids for initial treatment of minimal change disease: a single-center experience.
Front Pharmacol. 2025 Jan 6;15:1403562. doi: 10.3389/fphar.2024.1403562. eCollection 2024.
4
Detailed Pathophysiology of Minimal Change Disease: Insights into Podocyte Dysfunction, Immune Dysregulation, and Genetic Susceptibility.
Int J Mol Sci. 2024 Nov 13;25(22):12174. doi: 10.3390/ijms252212174.
5
Case Report of Minimal Change Disease in the Adult Population.
Cureus. 2024 Jun 13;16(6):e62306. doi: 10.7759/cureus.62306. eCollection 2024 Jun.
6
The efficacy and safety of rituximab with or without glucocorticoid in inducing remission of MCD with different clinical presentations in adults: a retrospective study.
Clin Kidney J. 2024 May 3;17(6):sfae139. doi: 10.1093/ckj/sfae139. eCollection 2024 Jun.
7
Early Rituximab as an Add-On Therapy in Children With the Initial Episode of Nephrotic Syndrome.
Kidney Int Rep. 2024 Feb 16;9(5):1220-1227. doi: 10.1016/j.ekir.2024.02.1395. eCollection 2024 May.
8
Prophylactic ultra-low dose rituximab to maintain remission in relapsing adult minimal change disease.
Clin Kidney J. 2023 Oct 19;17(1):sfad270. doi: 10.1093/ckj/sfad270. eCollection 2024 Jan.
9
The role of follicular helper T cells in the pathogenesis of allergic disease-related minimal change nephrotic syndrome.
CEN Case Rep. 2024 Feb;13(1):74-75. doi: 10.1007/s13730-023-00796-5. Epub 2023 May 8.
Zotero 插件